FUNGAL NAIL NIGHTTIME RENEWAL PATCHES

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: FUNGAL NAIL NIGHTTIME RENEWAL PATCHES
Generic name: TOLNAFTATE 1%
Manufacturer: 100 KARMA INC
Product type: HUMAN OTC DRUG
SPL set ID: 3b9ab6e0-8773-f909-e063-6394a90ac1c9
SPL ID: 55b634e3-ebde-f789-e063-6294a90a0a45
Version: 7
Effective date: 2026-07-03
Source export date: 2026-11-06
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/b0d9ca61dc485ebaf55e14a76d7d677668e40ef1e1978cdbcc4d73d58eba0b99/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:46:02

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		FUNGAL NAIL NIGHTTIME RENEWAL PATCHES	openfda.brand_name
generic name		TOLNAFTATE 1%	openfda.generic_name
manufacturer name		100 KARMA INC	openfda.manufacturer_name
ndc	package	85569-009-01	openfda.package_ndc
ndc	product	85569-009	openfda.product_ndc
ndc11	package	85569000901	derived:openfda.package_ndc
rxcui		2677690	openfda.rxcui
spl id		55b634e3-ebde-f789-e063-6294a90a0a45	id
spl set id		3b9ab6e0-8773-f909-e063-6394a90ac1c9	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only on children under 2 years ofage unless directed by a doctor on diaper rash Avoid contact with eyes. do not exceed the recommended daly dosage unless directed by a doctor. mirritation occurs. there is no improvement within 4 weeks. ask a health professional before use. in case of accidental ingestion, seek medical advice immediately or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.